학술논문

Prognostic value of PSA progression in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated in the COU-AA-302 trial.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2019, 37 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755